Ganji Purnachandra Nagaraju, MSc, PhD
Instructor, Hematology & Medical Oncology
Emory University School of Medicine
Office: Winship Cancer Institute of Emory University
Phone: (404) 778-3558
Fax: (404) 778-5520
Dr. G. Purnachandra Nagaraju received his MSc and his PhD, both in Biotechnology, from Sri Venkateswara University in Tirupati, Andhra Pradesh, India.
Dr. Nagaraju is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He also holds memberships with the Association of Scientists of Indian Origin in America, the Society for Integrative and Comparative Biology, the Science Advisory Board, The RNA Society and the American Association of Cancer Research.
Dr. Nagaraju's work mainly focuses on basic as well as translational cancer research. As a leading researcher in the cancer field, he is currently investigating the role of HSP-90 inhibitors, curcumin and its analogues in advanced cancers. His research focuses on translational projects related to gastrointestinal malignancies, specifically pancreatic and colorectal cancer, to bring observations derived from in vitro and in vivo models of cancer cell growth to the translational level. Dr. Nagaraju collaborates closely with clinicians in studies that target the HSP90, SPARC and DNMT-1 cell signaling pathways in pancreatic as well as colorectal cancer.